KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Income from Non-Controlling Interests: 2014-2020

Historic Income from Non-Controlling Interests for BeOne Medicines (ONC) over the last 5 years, with Dec 2020 value amounting to -$3.6 million.

  • BeOne Medicines' Income from Non-Controlling Interests fell 42.17% to $96,000 in Q4 2020 from the same period last year, while for Dec 2020 it was -$3.6 million, marking a year-over-year decrease of 85.49%. This contributed to the annual value of -$3.6 million for FY2020, which is 85.49% down from last year.
  • According to the latest figures from FY2020, BeOne Medicines' Income from Non-Controlling Interests is -$3.6 million, which was down 85.49% from -$1.9 million recorded in FY2019.
  • Over the past 5 years, BeOne Medicines' Income from Non-Controlling Interests peaked at -$194,000 during FY2017, and registered a low of -$3.6 million during FY2020.
  • Over the past 3 years, BeOne Medicines' median Income from Non-Controlling Interests value was -$1.9 million (recorded in 2019), while the average stood at -$1.9 million.
  • Data for BeOne Medicines' Income from Non-Controlling Interests shows a maximum YoY crashed of 638.64% (in 2019) over the last 5 years.
  • Yearly analysis of 4 years shows BeOne Medicines' Income from Non-Controlling Interests stood at -$194,000 in 2017, then plummeted by 36.08% to -$264,000 in 2018, then plummeted by 638.64% to -$1.9 million in 2019, then tumbled by 85.49% to -$3.6 million in 2020.